Get Real Time Here
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Acurx Pharmaceuticals Stock (NASDAQ:ACXP), Quotes and News Summary
Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
| Open1.600 | Close1.530 |
| Vol / Avg.68.348K / 33.436K | Mkt Cap19.898M |
| Day Range1.460 - 1.600 | 52 Wk Range1.530 - 4.610 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.290 | -0.280 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 13.00 |
| 2023-08-15 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Lowers | 14.00 | 13.00 |
| 2023-05-15 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 14.00 |
| 2023-04-11 | HC Wainwright & Co. | Ed Arce | Reiterates | Buy | Maintains | - | 14.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ACXP | Acurx Pharmaceuticals | -4.38% | 19.9M |
| VINC | Vincerx Pharma | 1.21% | 19.7M |
| ALZN | Alzamend Neuro | -3.93% | 21.3M |
| VIRI | Virios Therapeutics | 0% | 18.1M |
| CLRB | Cellectar Biosciences | 14.61% | 24.4M |
How do I buy Acurx Pharmaceuticals (ACXP) stock?
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Who are Acurx Pharmaceuticals's (ACXP) competitors?
Other companies in Acurx Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).
What is the target price for Acurx Pharmaceuticals (ACXP) stock?
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Wednesday, September 13, 2023. The analyst firm set a price target for 13.00 expecting ACXP to rise to within 12 months (a possible 749.67% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Acurx Pharmaceuticals (ACXP)?
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $1.53 last updated September 22, 2023 at 8:00 PM UTC.
Does Acurx Pharmaceuticals (ACXP) pay a dividend?
There is no dividend information for Acurx Pharmaceuticals.
When is Acurx Pharmaceuticals (NASDAQ:ACXP) reporting earnings?
Acurx Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Acurx Pharmaceuticals (ACXP) going to split?
There is no upcoming split for Acurx Pharmaceuticals.
What sector and industry does Acurx Pharmaceuticals (ACXP) operate in?
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.